The proportion of vasa vasora expressing IL‐33 (IL‐33+ vasa vasorum) was higher in RA patients compared with non‐RA patients (mean ± SEM 20.4 ± 15.8% versus 8.6 ± 9.5%; P = 0.02) (Figure 2A). This evidence concerns the gene IL33 and rheumatoid arthritis.